Skip to content

Drug prices are too high. What is Congress trying to do about it?

Chairman Charles E. Grassley, right, and ranking member Sen. Ron Wyden are seen before a Senate Finance Committee on drug pricing in America on February 26, 2019. (Tom Williams/CQ Roll Call)
Chairman Charles E. Grassley, right, and ranking member Sen. Ron Wyden are seen before a Senate Finance Committee on drug pricing in America on February 26, 2019. (Tom Williams/CQ Roll Call)

Both the House and the Senate have competing bills aimed at addressing the rising costs of prescription drugs, a legislative priority backed by President Donald Trump.

But what would these various proposals accomplish, and how likely is it they’ll be signed into law?

[jwp-video n=”1″]

Recent Stories

Trump endorsement question hangs over Nevada Senate race

Trump griped about trial but did not use holiday to hit multiple swing states

It’s past time to retire covering rallies as signs of momentum

‘Ready for the fight’: After narrow loss in 2022, Logan aims for Hayes’ Connecticut House seat

Strange things are afoot at the Capitol

Photos of the week ending May 24, 2024